A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice

References

• J Kassa. (2002). Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 40:803–816.
   PubMed Web of Science ®Google Scholar
• TC Marrs. (1993). Organophosphate poisoning. Pharmacol Ther 58:51–66.
   PubMed Web of Science ®Google Scholar
• J Cabal, and J Bajgar. (1999). Tabun – reappearance 50 years later (in Czech). Chem Listy 93:27–31.
   Web of Science ®Google Scholar
• F Ekström, C Akfur, AK Tunemalm, and S Lundberg. (2006). Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase. Biochemistry 45:74–81.
   PubMed Web of Science ®Google Scholar
• M Jokanovic, M Maksimovic, V Kilibarda, D Jovanovic, and D Savic. (1996). Oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates. Toxicol Lett 85:35–39.
   PubMed Web of Science ®Google Scholar
• J Bajgar. (2004). Organophosphate/nerve agent poisoning: Mechanism of action, diagnosis, prophylaxis and treatment. Adv Clin Chem 38:151–216.
   PubMed Web of Science ®Google Scholar
• I Koplovitz, and JR Stewart. (1994). A comparison of the efficacy of HI-6 and 2-PAM against soman, tabun, sarin and VX in the rabbit. Toxicol Lett 70:169–179.
   Web of Science ®Google Scholar
• J Kassa. (1995). Comparison of efficacy of two oximes (HI-6 and obidoxime) in soman poisoning in rats. Toxicology 101:167–174.
   PubMed Web of Science ®Google Scholar
• G Puu, E Artursson, and G Bucht. (1986). Reactivation of nerve agent inhibited acetylcholinesterases by HI-6 and obidoxime. Biochem Pharmacol 35:1505–1510.
   PubMed Web of Science ®Google Scholar
• F Worek, R Widmann, O Knopff, and L Szinicz. (1998). Reactivating potency of obidoxime, pralidoxime, HI-6 and HLö-7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol 72:237–243.
   PubMed Web of Science ®Google Scholar
• K Musilek, O Holas, K Kuca, D Jun, V Dohnal, V Opletalova, and M Dolezal. (2007). Synthesis of monooxime-monocarbamoyl bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesterase. J Enz Inhib Med Chem DOI: 101080/14756360701383981
   PubMed Web of Science ®Google Scholar
• K Musilek, O Holas, D Jun, V Dohnal, F Gunn-Moore, V Opletalova, M Dolezal, and K Kuca. (2007). Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker - Preparation and reactivation of tabun and paraoxon-inhibited acetylcholinesterase. Bioorg Med Chem 15:6733–6741.
   PubMed Web of Science ®Google Scholar
• R Tallarida, and R Murray. Manual of Pharmacological Calculation with Computer ProgramsNew York: Springer-Verlag; (1987).
   Google Scholar
• JG Clement, AS Hansen, and CA Boulet. (1992). Efficacy of HLö-7 and pyrimidoxime as antidotes of nerve agent poisoning in mice. Arch Toxicol 66:216–219.
   PubMed Web of Science ®Google Scholar
• GL Ellman, DK Courtney, VJr Andres, and RM Feartherstone. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–93.
   PubMed Web of Science ®Google Scholar
• K Kuca, and J Kassa. (2003). A comparison of the ability of a new bispyridinium oxime – 1-(4- hydroxyiminomethylpyridinium-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J Enz Inhib Med Chem 18:529–535.
   PubMed Web of Science ®Google Scholar
• K Musilek, O Holas, K Kuca, D Jun, V Dohnal, and M Dolezal. (2007). Synthesis of a novel non-symmetrical bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity using tabun and paraoxon-inhibited acetylcholinesterase. J Enz Inhib Med Chem 22:425–432.
   PubMed Web of Science ®Google Scholar
• J Cabal, K Kuca, and J Kassa. (2004). Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase. Pharmacol Toxicol 95:81–86.
   Google Scholar
• J Kassa, and J Cabal. (1999). A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 132:111–118.
   PubMed Web of Science ®Google Scholar
• J Kassa, and J Cabal. (1999). A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods. Hum Exp Toxicol 18:560–565.
   PubMed Web of Science ®Google Scholar
• J Kassa, and J Cabal. (1999). A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexylmethylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol Toxicol 84:41–45.
   PubMedGoogle Scholar
• K Kuca, D Jun, and K Musilek. (2006). Structural requirements of acetylcholinesterase reactivators. Mini Rev Med Chem 6:269–277.
   PubMed Web of Science ®Google Scholar
• J Bajgar, J Fusek, K Kuca, L Bartosova, and D Jun. (2007). Treatment of organophosphate intoxication using cholinesterase reactivators: Facts and fiction. Mini-Rev Med Chem 7:461–466.
   PubMed Web of Science ®Google Scholar
• J Kassa. (2006). The influence of oxime and anticholinergic drug selection on the potency of antidotal treatment to counteract acute toxic effects of tabun in mice. Neurotox Res 9:59–62.
   PubMed Web of Science ®Google Scholar
• J Kassa, K Kuca, L Bartosova, and G Kunesova. (2007). The development of new structural analogues of oximes for the antidotal treatment of poisoning by nerve agents and the comparison of their reactivating and therapeutic efficacy with currently available oximes. Curr Org Chem 11:267–283.
   Web of Science ®Google Scholar
• M Jokanovic, and M Maksimovic. (1995). A comparison of trimedoxime, obidoxime, pralidoxime and HI-6 in the treatment of oral organophosphorus insecticide poisoning in the rat. Arch Toxicol 70:119–123.
   PubMed Web of Science ®Google Scholar
• GA Petroianu, SM Nurulain, N Nagelkerke, M Shafiullah, J Kassa, and K Kuca. (2007). Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: Survival in rats exposed to methyl-paraoxon. J Appl Toxicol 27:453–457.
   PubMed Web of Science ®Google Scholar
• F Worek, T Kirchner, M Bäker, and L Szinicz. (1996). Reactivation by various oximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds. Arch Toxicol 70:497–503.
   PubMed Web of Science ®Google Scholar